PND46 THE RISKS OF MULTIPLE GENERIC SUBSTITUTION OF ANTIEPILEPTIC DRUGS- THE CASE OFTOPIRAMATE
Abstract
Authors
J Lelorier MS Duh PE Paradis D Latremouille-Viau O Sheehy P Greenberg SP Lee MF Rupnow
J Lelorier MS Duh PE Paradis D Latremouille-Viau O Sheehy P Greenberg SP Lee MF Rupnow
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now